3-Methylmethcathinone Intoxication: Discrepancies Between Blood Concentrations and Clinical Outcomes-A Short Communication.
Journal
Therapeutic drug monitoring
ISSN: 1536-3694
Titre abrégé: Ther Drug Monit
Pays: United States
ID NLM: 7909660
Informations de publication
Date de publication:
04 Sep 2023
04 Sep 2023
Historique:
received:
29
03
2023
accepted:
23
06
2023
medline:
9
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
aheadofprint
Résumé
The absence of a correlation between the blood concentration of 3-methylmethcathinone (3-MMC) and clinical outcomes in intoxication cases has been attributed to stability issues. Indeed, a loss of more than 50%, 70%, and even 95% of 3-MMC in whole blood after 2 weeks of storage at 20°C, 4°C, and room temperature, respectively, has been reported in the past. Here, the authors report the case of a 43-year-old man who was hospitalized with generalized convulsive status epilepticus related to 3-MMC use with a plasma concentration of 9600 ng/mL (delay between sampling and analysis <72 hours). The stability of 3-MMC was evaluated in several biological specimens. Three quality control samples (human plasma, whole blood, and postmortem blood) spiked with 3-MMC were stored at -20°C and 4°C for 14 days. The initial analysis was performed on day 1 to establish the initial concentration of 3-MMC in each specimen type, and the samples were divided into 2 aliquots for storage under both conditions. Further analyses were performed on days 7 and 14 for each specimen, and the results were compared with those obtained on day 1. 3-MMC appeared relatively stable in whole and postmortem blood when stored at -20°C for 1 week, with losses of <3% in both matrices (0% and 2.5%, respectively). At +4°C, 3-MMC losses ranged from 25% to 53%. These results differ from others reported in the literature. Hence, it may be hypothesized that other elements should be considered to explain the discrepancy between the concentration and toxicity pointed out by the Toxicology community, especially the development of tolerance.
Sections du résumé
BACKGROUND
BACKGROUND
The absence of a correlation between the blood concentration of 3-methylmethcathinone (3-MMC) and clinical outcomes in intoxication cases has been attributed to stability issues. Indeed, a loss of more than 50%, 70%, and even 95% of 3-MMC in whole blood after 2 weeks of storage at 20°C, 4°C, and room temperature, respectively, has been reported in the past. Here, the authors report the case of a 43-year-old man who was hospitalized with generalized convulsive status epilepticus related to 3-MMC use with a plasma concentration of 9600 ng/mL (delay between sampling and analysis <72 hours). The stability of 3-MMC was evaluated in several biological specimens.
METHODS
METHODS
Three quality control samples (human plasma, whole blood, and postmortem blood) spiked with 3-MMC were stored at -20°C and 4°C for 14 days. The initial analysis was performed on day 1 to establish the initial concentration of 3-MMC in each specimen type, and the samples were divided into 2 aliquots for storage under both conditions. Further analyses were performed on days 7 and 14 for each specimen, and the results were compared with those obtained on day 1.
RESULTS
RESULTS
3-MMC appeared relatively stable in whole and postmortem blood when stored at -20°C for 1 week, with losses of <3% in both matrices (0% and 2.5%, respectively). At +4°C, 3-MMC losses ranged from 25% to 53%.
CONCLUSIONS
CONCLUSIONS
These results differ from others reported in the literature. Hence, it may be hypothesized that other elements should be considered to explain the discrepancy between the concentration and toxicity pointed out by the Toxicology community, especially the development of tolerance.
Identifiants
pubmed: 37684715
doi: 10.1097/FTD.0000000000001134
pii: 00007691-990000000-00144
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Ferreira B, Dias da Silva DD, Carvalho F, et al. The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): a review. Forensic Sci Int. 2019;295:54–63.
EMCDDA Initial Report on the New Psychoactive Substance 2-(Methylamino)-1-(3-Methylphenyl)propan-1-one (3-Methylmethcathinone, 3-MMC). European Centre for Drugs and Drug Addiction. Available at: https://www.emcdda.europa.eu/system/files/publications/14341/EMCDDA-initial-report-3-MMC-advanced-release.pdf. Published 2021. Accessed December 2021.
Ameline A, Dumestre-Toulet V, Raul JS, Kintz P. Determination of a threshold fatal 3-MMC concentration in human: mission impossible. Psychopharmacology. 2019;236:865–867.
Jamey C, Kintz P, Martrille L, Raul JS. Fatal combination with 3-methylmethcathinone (3-MMC) and gamma-hydroxybutyric acid (GHB). J Anal Toxicol. 2016;40:546–552.
Drevin G, Briet M, Férec S, et al. Acute sodium oxybate intoxication: a case report and review of the literature. Ther Drug Monit. 2023;45:277–281.
La Maida N, Di Trana A, Giorgetti R, et al. A review of synthetic cathinone-related fatalities from 2017 to 2020. Ther Drug Monit. 2021;43:52–68.
Dias da Silva D, Ferreira B, Roque Bravo R, et al. The new psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone) induces oxidative stress, apoptosis, and autophagy in primary rat hepatocytes at human-relevant concentrations. Arch Toxicol. 2019;93:2617–2634.
Busardò FP, Kyriakou C, Tittarelli R, et al. Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens. Forensic Sci Int. 2015;256:28–37.
Aldubayyan AA, Castrignanò E, Elliott S, Abbate V. Stability of synthetic cathinones in clinical and forensic toxicological analysis – where are we now? Drug Test Anal. 2021;13:44–68.
Shimshoni JA, Britzi M, Sobol E, et al. 3-methyl-methcathinone: pharmacokinetic profile evaluation in pigs in relation to pharmacodynamics. J Psychopharmacol. 2015;29:734–743.
Bambagiotti G, Castaldo P, Tedeschi V, et al. Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties. Toxicologie Analytique et Clinique. 2022;34:S94–S95.
Foltin RW, Schuster CR. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats. J Pharmacol Exp Ther. 1982;222:126–131.
Schechter MD. Induction of and recovery from tolerance to the discriminative stimulus properties of l-cathinone. Pharmacol Biochem Behav. 1986;25:13–16.
Schechter MD. Rats become acutely tolerant to cathine after amphetamine or cathinone administration. Psychopharmacology. 1990;101:126–131.
Frison G, Frasson S, Zancanaro F, et al. Detection of 3-methylmethcathinone and its metabolites 3-methylephedrine and 3-methylnorephedrine in pubic hair samples by liquid chromatography–high resolution/high accuracy Orbitrap mass spectrometry. Forensic Sci Int. 2016;265:131–137.
Aknouche F, Maruejouls C, Kernalleguen A, et al. Fatal comedown after taking 3-methylmetcathinone (3-MMC): a case report. Toxicologie Analytique et Clinique. 2020;32:205–209.